Philippa Hofbrucker

Biography

Philippa is a partner in our Disputes and Investigations group.

She is trusted by major corporates, boards and senior executives in complex and high-stakes disputes. Her practice is consistently recognised in leading legal directories.

Philippa specialises in regulatory investigations and enforcement actions, class actions, commercial litigation and public inquiries. She also has expertise in risk mitigation in emerging regulatory focus areas, including AI governance, cyber and ESG.

Her clients span a broad range of industries, with particular depth of experience in financial services and health and life sciences.

Philippa combines forensic rigour with commercial pragmatism. She leverages advanced project management techniques and emerging technologies, including AI where appropriate, to deliver quality and cost-effective outcomes for her clients.

Experience

Philippa’s experience includes advising:

  • Leviat (a CRH company) in its defence of litigation relating to a construction product liability dispute. 

  • Macquarie Bank in its defence of a major consumer class action in relation to the provision of auto finance.

  • Downer EDI in its defence of a securities class action in relation to alleged continuous disclosure breaches and misleading or deceptive conduct.

  • Australian Clinical Labs in OAIC enforcement proceedings regarding a cyber security incident and related regulatory investigations.

  • SkyCity Adelaide in AUSTRAC enforcement proceedings alleging breaches of the AML/CTF laws.

  •  Westpac in:

    • ASIC and APRA investigations regarding director and officer duties, AFSL general obligations and the BEAR arising from alleged breaches of AML/CTF laws

    • ASIC investigation and enforcement proceedings regarding financial advice fees charged by its super businesses

    • ASIC investigations regarding the quality of advice of a former financial adviser and other retail bank matters

    • its response to the Banking Royal Commission 

    • ASIC investigation and enforcement proceedings into alleged manipulation of the BBSW.

  • National Dental Care in litigation in relation to a business purchase agreement.

  • Agilex Biolabs in its defence of litigation commenced by a former employee in relation to an ESOP.

  • Peregrine in its defence and cross-claim in litigation regarding a contractual dispute with Hungry Jacks.

  • A major financial institution in an ACCC investigation in relation to potential cartel conduct.

  • A major financial institution on a significant risk and compliance audit of anti-competitive and market misconduct.

  • A range of private equity sponsors including KKR, PEP, Quadrant, Adamantem and TPG Capital in relation to issues and disputes concerning their portfolio companies and proposed acquisitions.

  • A Goldman Sachs executive in an ASIC investigation relating to the Healthscope equities block trade.

  • The UK Serious Fraud Office in its defence of litigation commenced in connection with a discontinued bribery and corruption investigation.

  • Dadco Alumina in connection with a bribery and corruption investigation by the UK SFO.

  • Multiple directors, executives and employees of major corporations in compulsory examinations by regulators and appearances before royal commissions and parliamentary inquiries.

Awards and Recognition

  • The Legal 500 Asia-Pacific 2025

    Recommended as a key lawyer in Dispute Resolution: Class actions

  • The Legal 500 Asia-Pacific 2024

    Recommended as a key lawyer in Dispute Resolution: Financial Services Regulatory

  • The Legal 500 Asia-Pacific 2021

    Recommended as a key lawyer in Dispute Resolution: Litigation

  • The Best Lawyers in Australia 2027

    Recognised for Class Action Litigation and Litigation